Pfizer Sanctions Affirmed In Neurontin Antitrust MDL

Law360, New York (June 10, 2011, 1:53 PM EDT) -- A New Jersey federal judge on Thursday upheld sanctions against Pfizer Inc. for a witness testimony violation in a class action that accuses the pharmaceutical giant of using patent litigation to delay generic competition for epilepsy drug Neurontin.

U.S. District Judge Faith S. Hochberg rejected Pfizer and its subsidiary Warner-Lambert Co.'s appeal of the sanctions and affirmed the order handed down in January by Magistrate Judge Patty Shwartz sanctioning the companies for twice failing to produce a witness sufficiently prepared to testify about their off-label use...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.